This week, Russian Federation said it was clearing a homegrown vaccine for use by its general public, though researchers expressed concerns about the adequacy of evidence supporting the shot's safety and effectiveness.
In late July, the EU announced it had concluded exploratory talks with French pharmaceutical company Sanofi aiming for a deal that could secure 300 million doses of the company's COVID-19 vaccine for Europeans once it is developed and proven to be safe and effective against the coronavirus.
Novavax will also conduct a phase 3 clinical trial of its vaccine candidate with support from the UK's National Institute for Health Research (NIHR), and has partnered with FUJIFILM Diosynth Biotechnologies to manufacture certain components of the vaccine in the UK.
"The government's strategy to build a portfolio of promising vaccine candidates will ensure we have the best possible chance of finding one that works", said Business Secretary Alok Sharma.
As part of the pact, J&J will be transferring the technology for manufacturing its Covid-19 vaccine candidate to Hyderabad-based Bio E.
Vietnam health ministry to buy Russian COVID-19 vaccine -state media
Ltd. reached a deal with AstraZeneca and Novavax to supply their COVID-19 vaccines to middle and low-income countries this month. Even if India were to procure Sputnik V , its phase II and III trials on locals are necessary before approval for use.
"The UK government agrees on COVID-19 vaccine deals with both Novavax and Johnson & Johnson."The vaccine is based on technology used in its recently approved preventative Ebola vaccine created to induce long-term immunity in individuals over one years' old.
"Our citizens' lives and our economy need a safe and effective vaccine against the coronavirus".
The UK said it continued to work with the vaccine alliance GAVI, the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organisation and a group of other countries to help buy vaccines as well as to ensure equitable distribution of vaccines to low-income countries.
"It is encouraging that Novavax' recent clinical data shows their vaccine triggers an immune response greater than that in patients who have recovered from the disease", Kate Bingham, Chair of the UK Government's Vaccines Taskforce said in a statement.
"We are honored to partner with the United Kingdom government to deliver a vaccine that could provide vital protection in the fight against the global health crisis", said Novavax Chief Executive Stanley Erck.